BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 15183467)

  • 1. Melatonin as a radioprotective agent: a review.
    Vijayalaxmi ; Reiter RJ; Tan DX; Herman TS; Thomas CR
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):639-53. PubMed ID: 15183467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo.
    Andrievsky GV; Bruskov VI; Tykhomyrov AA; Gudkov SV
    Free Radic Biol Med; 2009 Sep; 47(6):786-93. PubMed ID: 19539750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin: from basic research to cancer treatment clinics.
    Vijayalaxmi ; Thomas CR; Reiter RJ; Herman TS
    J Clin Oncol; 2002 May; 20(10):2575-601. PubMed ID: 12011138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiobiological review on melatonin: a novel radioprotector.
    Shirazi A; Ghobadi G; Ghazi-Khansari M
    J Radiat Res; 2007 Jul; 48(4):263-72. PubMed ID: 17641465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage.
    Reiter RJ; Tan DX; Manchester LC; Tamura H
    J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():5-22. PubMed ID: 18212398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
    Reiter RJ; Tan DX; Mayo JC; Sainz RM; Leon J; Czarnocki Z
    Acta Biochim Pol; 2003; 50(4):1129-46. PubMed ID: 14740000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioprotective potential of ginseng.
    Lee TK; Johnke RM; Allison RR; O'Brien KF; Dobbs LJ
    Mutagenesis; 2005 Jul; 20(4):237-43. PubMed ID: 15956041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
    Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?
    Tan DX; Manchester LC; Terron MP; Flores LJ; Reiter RJ
    J Pineal Res; 2007 Jan; 42(1):28-42. PubMed ID: 17198536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular diseases: protective effects of melatonin.
    Tengattini S; Reiter RJ; Tan DX; Terron MP; Rodella LF; Rezzani R
    J Pineal Res; 2008 Jan; 44(1):16-25. PubMed ID: 18078444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal deterioration caused by carcinogens as a consequence of free radical mediated tissue damage: a review of the protective action of melatonin.
    Gultekin F; Hicyilmaz H
    Arch Toxicol; 2007 Oct; 81(10):675-81. PubMed ID: 17823789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioprotective effect of free radical scavenging enzymes.
    Jones JB; Cramer HM; Inch WR; Lampe HB
    J Otolaryngol; 1990 Oct; 19(5):299-306. PubMed ID: 2262946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review.
    Reiter RJ
    Braz J Med Biol Res; 1993 Nov; 26(11):1141-55. PubMed ID: 8136717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.